Clinical trial
Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in…
NCT00411801 · Octapharma, Industry · Terminated
Key facts
| NCT number | NCT00411801 |
|---|---|
| Title | Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) |
| Official title | A Blinded Non-inferiority Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) |
| Lead sponsor | Octapharma, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Thrombotic Thrombocytopenic Purpura (TTP) |
| Intervention type | Biological |
| Interventions | Uniplas, Cryosupernatant plasma |
| Enrollment | 8 |
| Start date | May 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Dec 15, 2006 |
| Last update posted | Jun 21, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: